Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
The Stock Market Is Soaring but These 2 Stocks Are Still Dirt Cheap Buys
09:17am, Saturday, 23'rd Nov 2024
Earlier this month, the S&P 500 hit a record high of more than 6,000 for the first time ever. Based on that, you might assume that stocks may be too expensive to buy right now as the average stock in
3 Dividend Stocks That Are Screaming Buys in November
07:20am, Saturday, 23'rd Nov 2024
Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.
AbbVie: Upgrading To 'Strong Buy' After Pullback
03:10pm, Friday, 22'nd Nov 2024
In recent days, financial market participants have remained pessimistic about AbbVie's prospects, mainly due to the data on clinical outcomes related to emraclidine. However, I believe Mr. Market over
Which Is A Better Pick: JNJ Stock Or AbbVie?
08:00am, Thursday, 21'st Nov 2024
Given its better prospects, we believe that AbbVie stock (NYSE: ABBV) is currently a better pharmaceutical pick over Johnson & Johnson stock (NYSE: JNJ). Both AbbVie and J&J trade at 15x forward expec
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?
10:06am, Wednesday, 20'th Nov 2024
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
My Dividend Stock Portfolio: New October Dividend Record - 100 Holdings With 15 Buys
08:10am, Wednesday, 20'th Nov 2024
Investment activity in October focused on Business Development Companies, with $1,300 added to the market. Adjusted dividend income in October of $789, up 25% Y/Y and up 11% sequentially. Main picks i
Where Will AbbVie Be in 5 Years?
10:00am, Tuesday, 19'th Nov 2024
Where Will AbbVie Be in 5 Years?
AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe
11:21am, Monday, 18'th Nov 2024
The European Commission approves ABBV's Elahere for the treatment of platinum-resistant ovarian cancer.
High-Conviction Investing - 4 Of The Best Dividend Stocks Money Can Buy
07:30am, Monday, 18'th Nov 2024
The current market presents a complex mix of opportunities and risks, influenced by the Trump presidency, Fed policies, and elevated valuations. These factors require careful stock selection. I am foc
Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the Dip
07:00am, Monday, 18'th Nov 2024
Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the Dip
ELAHERE is the first and only novel therapy approved in the European Union specifically for patients with folate receptor-alpha (FRα) positive, platinum-resistant ovarian cancer ELAHERE represents th
Can This Dividend King Ever Hit $400 After This Major Fail?
10:52am, Sunday, 17'th Nov 2024
Pharmaceutical giant AbbVie (NYSE:ABBV) has suffered a meltdown over the past week, with shares losing 15% of their value.
AbbVie Stock Falls 11% in a Month: Should You Buy the Dip?
11:10am, Friday, 15'th Nov 2024
Investors who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks set to return to robust growth next year.
Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock
05:50am, Friday, 15'th Nov 2024
The drugmaker has convincingly laid to rest the biggest threat to its top line.
Final Trades: Bitcoin, Abbvie and Baker Hughes
01:37pm, Thursday, 14'th Nov 2024
The Investment Committee reveals their final trades for today.
